首页> 外文OA文献 >The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion

【2h】

The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion

机译：癌症免疫疗法的新时代：靶向髓样衍生的抑制细胞以克服免疫逃避

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Paola De Cicco; Giuseppe Ercolano; Angela Ianaro;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Myeloid-derived suppressor cellsa new therapeutic target to overcome resistance to cancer immunotherapy [J] . Chesney Jason A., Mitchell Robert A., Yaddanapudi Kavitha Journal of Leukocyte Biology: An Official Publication of the Reticuloendothelial Society . 2017,第3期

机译：骨髓衍生的抑制剂细胞新的治疗目标，以克服癌症免疫疗法的抗性
2. Immune suppression by myeloid-derived suppressor cells, MDSCs, in MYCN-driven neuroblastoma provides a potential target for cancer immunotherapy [J] . Nina Eissler, Baldur Sveinbj?rnsson, Anna Kock, Journal for ImmunoTherapy of Cancer . 2014,第S3期

机译：MYCN驱动的神经母细胞瘤中髓样来源的抑制细胞MDSCs的免疫抑制为癌症免疫治疗提供了潜在的靶点
3. Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors [J] . Rikke B. Holmgaard, Dmitriy Zamarin, Alexander Lesokhin, EBioMedicine . 2016,第2期

机译：用集落刺激因子-1受体阻滞靶向髓样来源的抑制细胞可以逆转表达吲哚胺2,3-双加氧酶的肿瘤对免疫疗法的免疫抵抗
4. Depleting Myeloid-derived Suppressor Cells with Janus Synthetic Nanoparticle Antibodies As A Cancer Immunotherapy [C] . Jiaying Liu, Pallab Pradhan, Randall Toy, Society for Biomaterials annual meeting and exposition . 2019

机译：用Janus合成纳米颗粒抗体耗尽骨髓来源的抑制细胞作为癌症免疫治疗。
5. Myeloid-Derived Suppressor Cells Negatively Regulate T Cell Trafficking as a Novel Mechanism of Immune Evasion [D] . Ku, Amy. 2019

机译：骨髓衍生的抑制细胞对T细胞贩运的抑制性抑制细胞产生了负调节，作为免疫逃避的新机制
6. The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion [O] . Paola De Cicco, Giuseppe Ercolano, Angela Ianaro 2020

机译：癌症免疫疗法的新时代：靶向髓样衍生的抑制细胞以克服免疫逃避
7. Immune suppression by myeloid-derived suppressor cells, MDSCs, in MYCN-driven neuroblastoma provides a potential target for cancer immunotherapy [O] . 2014

机译：MYCN驱动的神经母细胞瘤中髓样来源的抑制细胞MDSC的免疫抑制为癌症免疫治疗提供了潜在的靶点
8. Role of Myeloid-Derived Suppressor Cells in the Immunotherapy of HER2/neu-Positive Breast Carcinomas [R] . Morales, J. K., Kmieciak, M., Manjili, M. H. 2009

机译：髓源性抑制细胞在HER2 / neu阳性乳腺癌免疫治疗中的作用

The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion

著录项

引文网络

相似文献

相关主题

期刊订阅